Maria Barrera,
Clayful
Scale the Bright Spots
Startups can address important mental health problems, but maintaining mental health in startup culture is challenging.
Vir Biotechnology president and CEO George Scangos paints a picture of the future of biotechnology, including a vision for building safe, ethical gene therapies for many common diseases. Furthermore, he adds, advances in genomics may also allow us to significantly improve the speed and safety of clinical trials for new drugs.
